Compare CGEN & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CGEN | TAYD |
|---|---|---|
| Founded | 1993 | 1955 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.8M | 180.5M |
| IPO Year | 2001 | 1995 |
| Metric | CGEN | TAYD |
|---|---|---|
| Price | $1.99 | $56.91 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $4.60 | N/A |
| AVG Volume (30 Days) | ★ 232.4K | 25.3K |
| Earning Date | 11-09-2026 | 10-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | N/A | ★ $41,649,673.00 |
| Revenue This Year | N/A | $25.09 |
| Revenue Next Year | N/A | $23.22 |
| P/E Ratio | ★ N/A | $401.07 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.43 | $43.14 |
| 52 Week High | $3.24 | $90.37 |
| Indicator | CGEN | TAYD |
|---|---|---|
| Relative Strength Index (RSI) | 41.76 | 46.95 |
| Support Level | $1.98 | $53.14 |
| Resistance Level | $2.37 | $58.27 |
| Average True Range (ATR) | 0.10 | 1.55 |
| MACD | 0.01 | 0.18 |
| Stochastic Oscillator | 36.36 | 74.98 |
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
Taylor Devices Inc is engaged in the design, development, manufacture and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment and structures. The company continues to develop new and technology products. The company manufactures and sells a group of very similar products that have many different applications for customers. These similar products are included in one of nine categories, namely, Seismic Dampers, Fluidicshoks, Crane and Industrial Buffers, Self-Adjusting Shock Absorbers, Liquid Die Springs, Vibration Dampers, Machined Springs, Custom Shock and Vibration Isolators, and Custom Actuators. It has presence in USA, Asia, and Others. Majority of revenue comes from USA.